Shanghai Pharmaceuticals (601607.SH): Metoprolol Tartrate Injection Passes Generic Drug Consistency Evaluation.

Financial news from Zhitong, Shanghai Pharmaceuticals (601607.SH) announced recently that its subsidiary Shanghai Hefeng Pharmaceutical Co., Ltd. (referred to as "Shanghai Hefeng") has received the "Drug Supplementary Application Approval Notice" (Notice Number: 2025B02097) issued by the National Medical Products Administration for its heavy sodium succinate adrenaline injection (specification: 1ml:2mg; hereinafter referred to as "the drug"), which has passed the evaluation of generic drug consistency.